Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Abacus Life (ABL) Financials

Abacus Life logo
$6.34 -0.07 (-1.01%)
As of 03:33 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Abacus Life

Annual Income Statements for Abacus Life

This table shows Abacus Life's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 32 9.52 -24
Consolidated Net Income / (Loss)		 32 9.03 -25
Net Income / (Loss) Continuing Operations		 34 9.03 -25
Total Pre-Tax Income 		33 11 -19
Total Revenue		 46 66 112
Net Interest Income / (Expense)		 -0.04 0.00 0.00
Total Interest Income		 0.00 0.00 0.00
Total Interest Expense		 0.04 0.00 0.00
Total Non-Interest Income		 46 66 112
Service Charges on Deposit Accounts		 - 61 103
Other Non-Interest Income		 2.94 5.21 9.10
Total Non-Interest Expense		 11 42 113
Marketing Expense		 2.60 4.91 9.06
Other Operating Expenses		 7.40 35 96
Depreciation Expense		 0.00 3.41 7.91
Other Special Charges		 1.05 -1.37 0.24
Nonoperating Income / (Expense), net		 -0.35 -14 -19
Income Tax Expense		 0.89 1.47 5.48
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.70 -0.48 -0.96
Basic Earnings per Share		 $0.63 $0.17 ($0.34)
Weighted Average Basic Shares Outstanding		 50.37M 56.95M 70.76M
Diluted Earnings per Share		 $0.63 $0.16 ($0.34)
Weighted Average Diluted Shares Outstanding		 50.37M 57.77M 70.76M
Weighted Average Basic & Diluted Shares Outstanding		 - 63.69M 96.85M

Quarterly Income Statements for Abacus Life

This table shows Abacus Life's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 9.99 7.63 8.09 6.75 0.90 -6.22 -1.35 0.77 -5.13 -18 4.64
Consolidated Net Income / (Loss)		 10 7.56 7.62 6.72 1.05 -6.36 -1.28 0.65 -5.28 -19 5.40
Net Income / (Loss) Continuing Operations		 11 8.69 7.82 6.96 -0.29 -5.45 -1.06 0.79 -4.10 -21 5.40
Total Pre-Tax Income 		11 8.02 6.97 7.91 6.30 -11 -0.10 2.41 -5.54 -16 7.73
Total Revenue		 12 26 11 12 23 21 22 29 29 32 44
Net Interest Income / (Expense)		 0.00 -0.04 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Income		 0.00 -0.00 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Interest Expense		 0.00 0.04 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Total Non-Interest Income		 12 26 11 12 23 21 22 29 29 32 44
Other Non-Interest Income		 0.76 - 0.61 0.71 4.39 -0.50 1.91 2.27 2.36 2.57 44
Total Non-Interest Expense		 0.84 16 2.86 3.13 15 21 19 22 21 50 23
Marketing Expense		 0.01 - 0.73 0.68 1.70 1.79 1.93 2.55 2.17 2.41 2.62
Other Operating Expenses		 0.58 15 2.25 3.12 11 19 17 18 18 43 16
Depreciation Expense		 0.00 - 0.00 0.00 1.69 1.71 1.68 1.75 1.75 2.73 4.76
Other Special Charges		 0.25 - -0.13 -0.67 0.31 -0.88 -1.16 0.36 -0.42 1.46 -0.27
Nonoperating Income / (Expense), net		 0.04 - -0.56 -0.46 -3.54 -9.06 -2.36 -4.36 -12 0.56 -13
Income Tax Expense		 0.35 - -0.66 1.18 1.71 -0.77 1.17 1.76 -0.25 2.80 2.33
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.36 - -0.46 -0.03 0.15 -0.14 0.07 -0.12 -0.16 -0.75 0.76
Basic Earnings per Share		 $0.20 - $0.16 $0.13 $0.01 ($0.13) ($0.02) $0.01 ($0.07) ($0.26) $0.05
Weighted Average Basic Shares Outstanding		 50.37M 50.37M 50.37M 50.51M 63.35M 56.95M 63.03M 63.85M 74.69M 70.76M 96.19M
Diluted Earnings per Share		 $0.20 - $0.16 $0.13 $0.01 ($0.14) ($0.02) $0.01 ($0.07) ($0.26) $0.05
Weighted Average Diluted Shares Outstanding		 50.37M 50.37M 50.37M 50.51M 63.35M 57.77M 63.03M 67.16M 74.69M 70.76M 97.50M
Weighted Average Basic & Diluted Shares Outstanding		 18.34M 0.00 11.48M 62.96M 63.35M 63.69M 63.93M 74.65M 74.68M 96.85M 96.85M

Annual Cash Flow Statements for Abacus Life

This table details how cash moves in and out of Abacus Life's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 30 -4.46 106
Net Cash From Operating Activities		 11 -64 -209
Net Cash From Continuing Operating Activities		 11 -64 -209
Net Income / (Loss) Continuing Operations		 32 9.03 -25
Consolidated Net Income / (Loss)		 32 9.03 -25
Depreciation Expense		 0.00 3.41 7.91
Amortization Expense		 0.00 0.04 0.94
Non-Cash Adjustments to Reconcile Net Income		 -3.72 -6.80 0.79
Changes in Operating Assets and Liabilities, net		 -18 -70 -194
Net Cash From Investing Activities		 -3.70 2.24 -4.96
Net Cash From Continuing Investing Activities		 -3.70 2.24 -4.96
Purchase of Property, Leasehold Improvements and Equipment		 0.00 -0.19 -0.79
Purchase of Investment Securities		 -0.80 -0.35 -3.65
Other Investing Activities, net		 -2.90 2.78 -0.52
Net Cash From Financing Activities		 23 57 320
Net Cash From Continuing Financing Activities		 23 57 320
Issuance of Debt		 30 124 198
Issuance of Common Equity		 - 0.00 182
Repayment of Debt		 0.00 -26 -32
Repurchase of Common Equity		 0.00 -1.28 -11
Payment of Dividends		 -7.07 -24 -1.16
Other Financing Activities, Net		 0.00 -16 -16
Cash Interest Paid		 0.00 4.04 12
Cash Income Taxes Paid		 0.00 0.15 2.15

Quarterly Cash Flow Statements for Abacus Life

This table details how cash moves in and out of Abacus Life's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Net Change in Cash & Equivalents		 1.00 26 -10 0.89 16 -11 40 26 -72 113 -88
Net Cash From Operating Activities		 -1.64 17 -17 -21 -12 -14 2.27 -67 -52 -92 -62
Net Cash From Continuing Operating Activities		 -1.64 17 -17 -21 -12 -14 2.27 -67 -52 -92 -62
Net Income / (Loss) Continuing Operations		 10 10 7.62 6.72 1.05 -6.36 -1.28 0.65 -5.28 -19 5.40
Consolidated Net Income / (Loss)		 10 10 7.62 6.72 1.05 -6.36 -1.28 0.65 -5.28 -19 5.40
Depreciation Expense		 0.00 0.00 0.00 0.00 1.69 1.71 1.68 1.75 1.75 2.73 4.76
Amortization Expense		 - - 0.00 - 0.13 -0.09 0.09 0.36 0.19 0.30 0.49
Non-Cash Adjustments to Reconcile Net Income		 -57 61 -1.02 -0.45 -4.75 -0.58 5.39 -5.93 -3.02 4.34 -71
Changes in Operating Assets and Liabilities, net		 45 -54 -24 -27 -9.99 -8.49 -3.63 -64 -46 -80 -1.74
Net Cash From Investing Activities		 -1.68 -1.77 -1.00 -6.06 9.63 -0.33 -0.01 -0.71 -0.45 -3.79 -3.74
Net Cash From Continuing Investing Activities		 -1.68 -1.77 -1.00 -6.06 9.63 -0.33 -0.01 -0.71 -0.45 -3.79 -3.74
Purchase of Property, Leasehold Improvements and Equipment		 - - 0.00 - -0.10 -0.09 -0.16 -0.19 -0.24 -0.19 -0.22
Purchase of Investment Securities		 - -0.55 -0.15 -0.15 -0.05 - -0.09 -0.11 -0.10 -3.35 -3.52
Net Cash From Financing Activities		 4.33 11 8.05 28 18 3.08 38 93 -19 208 -23
Net Cash From Continuing Financing Activities		 4.33 11 8.05 28 18 3.08 38 93 -19 208 -23
Issuance of Debt		 3.44 17 8.05 52 27 37 43 9.03 15 132 16
Repayment of Debt		 - - - - - -26 - - - - -39
Repurchase of Common Equity		 - - 0.00 - - -1.28 -7.52 -3.22 - - 0.00
Other Financing Activities, Net		 1.82 -2.50 0.00 -0.69 -8.74 -6.10 2.14 -3.19 -1.68 -13 -0.47
Cash Interest Paid		 - - 0.00 0.77 0.56 2.71 1.69 2.94 3.22 3.76 5.37
Cash Income Taxes Paid		 - - 0.00 - - 0.15 0.00 2.69 - -0.55 0.00

Annual Balance Sheets for Abacus Life

This table presents Abacus Life's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Total Assets		 59 332 874
Cash and Due from Banks		 30 26 132
Trading Account Securities		 1.89 3.45 2.21
Loans and Leases, Net of Allowance		 0.00 0.00 0.00
Customer and Other Receivables		 0.00 1.01 1.53
Premises and Equipment, Net		 0.02 0.40 1.03
Goodwill		 0.00 140 238
Intangible Assets		 0.00 30 80
Other Assets		 27 131 419
Total Liabilities & Shareholders' Equity		 59 332 874
Total Liabilities		 31 168 451
Interest Bearing Deposits		 0.00 0.51 2.47
Short-Term Debt		 0.04 13 38
Accrued Interest Payable		 0.96 5.22 7.14
Other Short-Term Payables		 0.31 4.57 14
Long-Term Debt		 28 127 342
Other Long-Term Liabilities		 1.39 18 46
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 28 164 423
Total Preferred & Common Equity		 27 164 424
Preferred Stock		 0.00 0.00 0.00
Total Common Equity		 27 164 424
Common Stock		 0.71 200 494
Retained Earnings		 25 -35 -58
Treasury Stock		 0.00 -1.28 -12
Accumulated Other Comprehensive Income / (Loss)		 1.05 0.11 0.00
Noncontrolling Interest		 0.90 0.14 -0.86

Quarterly Balance Sheets for Abacus Life

This table presents Abacus Life's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025
Total Assets		 100 30 277 304 377 484 477 857
Cash and Due from Banks		 1.67 0.06 21 37 65 91 19 44
Trading Account Securities		 - - 1.00 1.00 4.66 5.17 4.20 2.74
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Customer and Other Receivables		 - - 0.08 1.00 - 1.17 1.28 1.67
Premises and Equipment, Net		 - - 0.18 0.26 0.55 0.69 0.89 1.18
Goodwill		 - - 140 140 140 140 140 238
Intangible Assets		 - - 33 31 28 26 25 75
Other Assets		 0.31 0.18 82 92 138 219 287 494
Total Liabilities & Shareholders' Equity		 100 30 277 304 377 484 477 857
Total Liabilities		 30 20 117 138 211 227 219 421
Interest Bearing Deposits		 - - 0.98 0.35 0.67 1.44 0.92 0.60
Short-Term Debt		 4.92 5.58 0.40 0.00 16 46 14 118
Accrued Interest Payable		 7.94 10 1.12 0.89 2.32 2.47 5.14 3.27
Other Short-Term Payables		 - - 11 4.22 5.19 5.71 3.66 8.83
Long-Term Debt		 - - 91 119 170 151 167 238
Other Long-Term Liabilities		 17 4.15 12 14 17 20 29 52
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Redeemable Noncontrolling Interest		 98 29 - - - - - 5.00
Total Equity & Noncontrolling Interests		 -27 -20 160 166 165 257 258 431
Total Preferred & Common Equity		 -27 -20 160 166 165 257 258 431
Preferred Stock		 0.00 0.00 - - 0.00 0.00 0.00 0.00
Total Common Equity		 -27 -20 160 166 165 257 258 431
Common Stock		 0.03 0.00 189 194 210 303 310 496
Retained Earnings		 -28 -20 -29 -29 -36 -35 -40 -53
Treasury Stock		 - - - - -8.81 -12 -12 -12
Noncontrolling Interest		 - - 0.36 0.29 0.21 0.08 -0.09 -0.10

Annual Metrics And Ratios for Abacus Life

This table displays calculated financial ratios and metrics derived from Abacus Life's official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 74,422,038.71% 43.91% 68.56%
EBITDA Growth		 118.64% -21.42% -71.15%
EBIT Growth		 121.88% -31.25% -103.68%
NOPAT Growth		 106.59% -36.58% -103.00%
Net Income Growth		 104.47% -72.10% -375.81%
EPS Growth		 0.00% -74.60% -312.50%
Operating Cash Flow Growth		 964.76% -698.92% -226.04%
Free Cash Flow Firm Growth		 0.00% -176.97% -120.93%
Invested Capital Growth		 -82.27% 438.44% 164.61%
Revenue Q/Q Growth		 127.42% -7.10% 16.07%
EBITDA Q/Q Growth		 18.50% -23.43% -59.18%
EBIT Q/Q Growth		 19.04% -29.43% -107.37%
NOPAT Q/Q Growth		 22.44% -28.92% -120.21%
Net Income Q/Q Growth		 23.20% -60.65% -103.03%
EPS Q/Q Growth		 0.00% 0.00% -54.55%
Operating Cash Flow Q/Q Growth		 258.75% -93.23% -59.25%
Free Cash Flow Firm Q/Q Growth		 0.00% -25.80% -232.54%
Invested Capital Q/Q Growth		 -25.25% 6.66% 83.34%
Profitability Metrics		 - - -
EBITDA Margin		 76.07% 41.53% 7.11%
EBIT Margin		 76.06% 36.33% -0.79%
Profit (Net Income) Margin		 70.19% 13.61% -22.26%
Tax Burden Percent		 97.33% 86.02% 128.22%
Interest Burden Percent		 94.82% 43.53% 2,187.69%
Effective Tax Rate		 2.67% 13.98% 0.00%
Return on Invested Capital (ROIC)		 17.47% 11.52% -0.11%
ROIC Less NNEP Spread (ROIC-NNEP)		 15.21% -2.42% -9.45%
Return on Net Nonoperating Assets (RNNOA)		 1.31% -2.12% -8.37%
Return on Equity (ROE)		 18.78% 9.40% -8.48%
Cash Return on Invested Capital (CROIC)		 157.22% -125.83% -90.40%
Operating Return on Assets (OROA)		 17.33% 12.34% -0.15%
Return on Assets (ROA)		 15.99% 4.62% -4.13%
Return on Common Equity (ROCE)		 -0.05% 9.35% -8.50%
Return on Equity Simple (ROE_SIMPLE)		 118.85% 5.51% -5.87%
Net Operating Profit after Tax (NOPAT)		 33 21 -0.62
NOPAT Margin		 70.92% 31.25% -0.56%
Net Nonoperating Expense Percent (NNEP)		 2.26% 13.94% 9.33%
SG&A Expenses to Revenue		 5.63% 7.39% 8.10%
Operating Expenses to Revenue		 23.94% 63.67% 100.79%
Earnings before Interest and Taxes (EBIT)		 35 24 -0.89
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 35 28 7.96
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 6.84 3.73 1.38
Price to Tangible Book Value (P/TBV)		 6.84 0.00 5.51
Price to Revenue (P/Rev)		 4.04 9.22 5.22
Price to Earnings (P/E)		 5.88 64.30 0.00
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 17.00% 1.56% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 3.29 2.39 1.04
Enterprise Value to Revenue (EV/Rev)		 4.02 10.94 7.44
Enterprise Value to EBITDA (EV/EBITDA)		 5.29 26.34 104.64
Enterprise Value to EBIT (EV/EBIT)		 5.29 30.11 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 5.67 35.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 17.35 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.63 0.00 0.00
Leverage & Solvency		 - - -
Debt to Equity		 1.01 0.85 0.90
Long-Term Debt to Equity		 1.00 0.77 0.81
Financial Leverage		 0.09 0.87 0.89
Leverage Ratio		 1.17 2.03 2.05
Compound Leverage Factor		 1.11 0.89 44.92
Debt to Total Capital		 50.12% 46.01% 47.36%
Short-Term Debt to Total Capital		 0.07% 4.29% 4.78%
Long-Term Debt to Total Capital		 50.05% 41.72% 42.58%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 1.59% 0.05% -0.11%
Common Equity to Total Capital		 48.28% 53.94% 52.75%
Debt to EBITDA		 0.81 5.07 47.85
Net Debt to EBITDA		 -0.05 4.14 31.27
Long-Term Debt to EBITDA		 0.80 4.60 43.02
Debt to NOPAT		 0.86 6.74 -612.43
Net Debt to NOPAT		 -0.05 5.50 -400.24
Long-Term Debt to NOPAT		 0.86 6.11 -550.63
Noncontrolling Interest Sharing Ratio		 100.29% 0.54% -0.12%
Liquidity Ratios		 - - -
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 295 -227 -501
Operating Cash Flow to CapEx		 0.00% -33,765.51% -26,558.24%
Free Cash Flow to Firm to Interest Expense		 6,882.25 0.00 0.00
Operating Cash Flow to Interest Expense		 249.85 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 249.85 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.23 0.34 0.19
Fixed Asset Turnover		 0.00 316.70 157.00
Capital & Investment Metrics		 - - -
Invested Capital		 56 304 804
Invested Capital Turnover		 0.25 0.37 0.20
Increase / (Decrease) in Invested Capital		 -262 247 500
Enterprise Value (EV)		 186 726 833
Market Capitalization		 186 612 585
Book Value per Share		 $1.49 $2.59 $5.68
Tangible Book Value per Share		 $1.49 ($0.09) $1.42
Total Capital		 56 304 804
Total Debt		 28 140 381
Total Long-Term Debt		 28 127 342
Net Debt		 -1.76 114 249
Capital Expenditures (CapEx)		 0.00 0.19 0.79
Net Nonoperating Expense (NNE)		 0.34 12 24
Net Nonoperating Obligations (NNO)		 28 140 381
Total Depreciation and Amortization (D&A)		 0.00 3.45 8.85
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.34)
Adjusted Weighted Average Basic Shares Outstanding		 32.26M 0.00 70.76M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.34)
Adjusted Weighted Average Diluted Shares Outstanding		 32.26M 0.00 70.76M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 96.85M
Normalized Net Operating Profit after Tax (NOPAT)		 34 20 -0.46
Normalized NOPAT Margin		 73.12% 29.48% -0.41%
Pre Tax Income Margin		 72.12% 15.82% -17.36%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 819.98 0.00 0.00
NOPAT to Interest Expense		 764.60 0.00 0.00
EBIT Less CapEx to Interest Expense		 819.98 0.00 0.00
NOPAT Less CapEx to Interest Expense		 764.60 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 21.82% 263.34% -4.68%
Augmented Payout Ratio		 21.82% 277.54% -47.78%

Quarterly Metrics And Ratios for Abacus Life

This table displays calculated financial ratios and metrics derived from Abacus Life's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 62,578,810.53% 99,433,800.00% 58,756,900.00% 39.70% 96.10% -19.64% 105.22% 149.56% 25.79% 52.14% 105.42%
EBITDA Growth		 8.76% 140.70% -17.68% 61.32% -6.57% -90.07% -45.00% 4.79% -3.49% -1,741.53% 552.43%
EBIT Growth		 8.75% 149.47% -17.40% 61.34% -23.11% -107.40% -67.99% -19.70% -5.46% -2,538.99% 833.23%
NOPAT Growth		 1.48% 446.52% -11.85% 36.58% -30.51% -114.07% -80.85% -74.27% -33.10% -939.75% 830.79%
Net Income Growth		 -3.79% 417.21% -18.75% 32.19% -89.85% -184.17% -116.73% -90.31% -602.85% -198.66% 523.30%
EPS Growth		 0.00% 0.00% 0.00% 44.44% -95.00% 0.00% -112.50% -92.31% -800.00% -85.71% 350.00%
Operating Cash Flow Growth		 -302.73% 5,117.48% -6,093.54% -369.37% -621.86% -180.82% 113.04% -218.39% -340.54% -565.98% -2,549.63%
Free Cash Flow Firm Growth		 821.02% 0.00% 4,963.96% 624.49% -180.38% -192.12% -204.27% -349.83% 26.38% -105.95% -27.42%
Invested Capital Growth		 -76.17% -82.27% -95.30% -22.44% 277.35% 438.44% 2,181.07% 80.08% 53.94% 164.61% 125.44%
Revenue Q/Q Growth		 41.57% 117.43% -59.09% 10.94% 98.72% -10.89% -6.38% 34.90% 0.17% 7.77% 39.64%
EBITDA Q/Q Growth		 107.10% -15.21% -17.59% 11.48% 19.94% -90.99% -0.84% 112.42% 10.47% -253.27% 272.10%
EBIT Q/Q Growth		 107.12% -15.21% -17.59% 11.48% -1.28% -108.16% -7.03% 179.64% 16.22% -327.87% 214.90%
NOPAT Q/Q Growth		 97.95% -22.27% 2.74% -13.61% 0.72% -115.74% 152.18% 16.12% 161.81% -344.70% 225.12%
Net Income Q/Q Growth		 103.60% -26.98% 0.84% -11.82% -84.37% -705.61% 79.96% 151.10% -910.87% -259.70% 128.40%
EPS Q/Q Growth		 122.22% 0.00% 0.00% -18.75% -92.31% -1,500.00% 85.71% 150.00% -800.00% -271.43% 119.23%
Operating Cash Flow Q/Q Growth		 63.22% 1,139.35% -201.71% -20.73% 43.44% -16.37% 116.99% -3,046.89% 21.74% -75.93% 33.04%
Free Cash Flow Firm Q/Q Growth		 1,748.30% 7.24% 18.77% -75.02% -352.59% -22.92% -33.42% 40.14% 25.56% -243.84% 16.83%
Invested Capital Q/Q Growth		 -76.77% -25.25% -72.72% 1,537.42% 13.03% 6.66% 15.55% 29.27% -3.38% 83.34% -1.55%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 92.92% 36.24% 73.00% 73.35% 44.27% 4.48% 19.56% 30.80% 33.97% -48.31% 59.54%
EBIT Margin		 92.91% 36.23% 72.99% 73.34% 36.43% -3.34% 11.38% 23.60% 27.38% -57.90% 47.64%
Profit (Net Income) Margin		 87.09% 29.25% 72.09% 57.30% 4.51% -30.64% -5.88% 2.23% -18.02% -60.14% 12.23%
Tax Burden Percent		 96.71% 94.31% 109.42% 85.02% 16.68% 59.63% 1,250.98% 27.05% 95.48% 117.30% 69.82%
Interest Burden Percent		 96.92% 85.60% 90.27% 91.90% 74.16% 1,539.16% -4.13% 34.87% -68.92% 88.55% 36.78%
Effective Tax Rate		 3.29% 0.00% -9.42% 14.98% 27.15% 0.00% 0.00% 72.95% 0.00% 0.00% 30.18%
Return on Invested Capital (ROIC)		 8.97% 7.64% 25.76% 12.62% 12.19% -2.00% 2.89% 1.60% 4.36% -7.50% 7.83%
ROIC Less NNEP Spread (ROIC-NNEP)		 10.25% 4.57% 8.43% 11.77% 2.31% -8.23% -0.09% 0.78% -2.37% -10.29% 4.41%
Return on Net Nonoperating Assets (RNNOA)		 0.17% 0.40% 0.18% 2.22% 1.21% -7.20% -0.10% 0.54% -1.68% -9.13% 3.97%
Return on Equity (ROE)		 9.14% 8.03% 25.93% 14.84% 13.40% -9.20% 2.79% 2.14% 2.68% -16.62% 11.81%
Cash Return on Invested Capital (CROIC)		 0.00% 157.22% 200.07% 36.93% -100.00% -125.83% -183.01% -55.72% -41.63% -90.40% -74.90%
Operating Return on Assets (OROA)		 8.44% 8.25% 22.05% 14.14% 12.87% -1.13% 4.08% 5.61% 6.76% -10.75% 10.40%
Return on Assets (ROA)		 7.91% 6.66% 21.78% 11.05% 1.59% -10.41% -2.11% 0.53% -4.45% -11.16% 2.67%
Return on Common Equity (ROCE)		 -1.35% -0.02% -2.96% 4.28% 7.83% -9.15% 2.32% 2.14% 2.68% -16.65% 11.71%
Return on Equity Simple (ROE_SIMPLE)		 -95.66% 0.00% -156.94% 20.15% 13.85% 0.00% 0.08% -2.31% -4.76% 0.00% -4.24%
Net Operating Profit after Tax (NOPAT)		 10 8.02 8.24 7.12 7.17 -1.13 1.58 1.83 4.79 -12 15
NOPAT Margin		 86.75% 31.01% 77.89% 60.66% 30.74% -5.43% 7.27% 6.25% 16.35% -37.12% 33.26%
Net Nonoperating Expense Percent (NNEP)		 -1.27% 3.06% 17.33% 0.86% 9.89% 6.23% 2.98% 0.82% 6.73% 2.80% 3.43%
SG&A Expenses to Revenue		 0.13% 0.00% 6.89% 5.83% 7.31% 8.61% 8.89% 8.72% 7.40% 7.63% 5.93%
Operating Expenses to Revenue		 7.09% 63.77% 27.01% 26.66% 63.57% 103.34% 88.62% 76.40% 72.62% 157.90% 52.36%
Earnings before Interest and Taxes (EBIT)		 11 9.37 7.72 8.61 8.49 -0.69 2.47 6.91 8.03 -18 21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 11 9.37 7.72 8.61 10 0.93 4.25 9.02 9.96 -15 26
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 6.84 0.00 0.72 2.59 3.73 4.70 2.15 2.93 1.38 1.68
Price to Tangible Book Value (P/TBV)		 0.00 6.84 0.00 0.00 0.00 0.00 0.00 6.11 8.08 5.51 6.19
Price to Revenue (P/Rev)		 21.36 4.04 3.32 1.92 6.02 9.22 10.65 6.12 7.83 5.22 5.39
Price to Earnings (P/E)		 16.98 5.88 6.19 3.55 18.40 64.30 9,417.59 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 5.89% 17.00% 16.16% 28.18% 5.43% 1.56% 0.01% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 5.78 3.29 12.57 0.74 1.80 2.39 2.55 1.45 2.09 1.04 1.32
Enterprise Value to Revenue (EV/Rev)		 21.51 4.02 3.41 3.10 7.17 10.94 12.30 7.29 9.51 7.44 7.75
Enterprise Value to EBITDA (EV/EBITDA)		 14.74 5.29 5.79 5.06 14.23 26.34 46.10 33.19 47.01 104.64 34.51
Enterprise Value to EBIT (EV/EBIT)		 14.80 5.29 5.78 5.06 14.99 30.11 63.05 52.64 76.02 0.00 58.29
Enterprise Value to NOPAT (EV/NOPAT)		 16.33 5.67 6.26 5.54 17.55 35.00 2,552.08 127.52 297.95 0.00 83.28
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 17.35 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.63 0.56 1.75 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.07 1.01 0.57 0.57 0.72 0.85 1.12 0.77 0.70 0.90 0.82
Long-Term Debt to Equity		 0.00 1.00 0.00 0.57 0.72 0.77 1.03 0.59 0.65 0.81 0.55
Financial Leverage		 0.02 0.09 0.02 0.19 0.52 0.87 1.09 0.69 0.71 0.89 0.90
Leverage Ratio		 1.16 1.17 1.12 1.28 1.71 2.03 2.32 1.82 1.84 2.05 2.05
Compound Leverage Factor		 1.12 1.01 1.01 1.18 1.27 31.30 -0.10 0.64 -1.27 1.82 0.75
Debt to Total Capital		 6.52% 50.12% 36.22% 36.33% 41.70% 46.01% 52.91% 43.42% 41.19% 47.36% 44.98%
Short-Term Debt to Total Capital		 6.52% 0.07% 36.22% 0.16% 0.00% 4.29% 4.46% 10.08% 3.22% 4.78% 14.92%
Long-Term Debt to Total Capital		 0.00% 50.05% 0.00% 36.17% 41.70% 41.72% 48.46% 33.33% 37.97% 42.58% 30.06%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 129.88% 1.59% 190.55% 0.14% 0.10% 0.05% 0.06% 0.02% -0.02% -0.11% 0.62%
Common Equity to Total Capital		 -36.40% 48.28% -126.77% 63.53% 58.19% 53.94% 47.03% 56.57% 58.83% 52.75% 54.40%
Debt to EBITDA		 0.17 0.81 0.17 2.49 3.30 5.07 9.56 9.92 9.27 47.85 11.79
Net Debt to EBITDA		 -3.21 -0.05 -0.71 1.92 2.28 4.14 6.19 5.33 8.27 31.27 10.34
Long-Term Debt to EBITDA		 0.00 0.80 0.00 2.48 3.30 4.60 8.75 7.62 8.54 43.02 7.88
Debt to NOPAT		 0.18 0.86 0.18 2.73 4.07 6.74 528.99 38.13 58.72 -612.43 28.44
Net Debt to NOPAT		 -3.56 -0.05 -0.77 2.10 2.81 5.50 342.84 20.46 52.41 -400.24 24.94
Long-Term Debt to NOPAT		 0.00 0.86 0.00 2.71 4.07 6.11 484.44 29.28 54.13 -550.63 19.01
Noncontrolling Interest Sharing Ratio		 114.82% 100.29% 111.42% 71.13% 41.56% 0.54% 16.87% 0.10% 0.05% -0.12% 0.85%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 252 270 320 80 -202 -249 -334 -200 -149 -512 -426
Operating Cash Flow to CapEx		 0.00% 0.00% 0.00% 0.00% -12,270.86% -14,858.81% 1,401.30% -35,324.72% -21,557.08% -47,714.70% -27,450.38%
Free Cash Flow to Firm to Interest Expense		 0.00 6,304.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 399.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 399.28 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.09 0.23 0.30 0.19 0.35 0.34 0.36 0.24 0.25 0.19 0.22
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 316.70 0.00 207.81 167.65 157.00 155.56
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 76 56 15 252 285 304 351 454 439 804 792
Invested Capital Turnover		 0.10 0.25 0.33 0.21 0.40 0.37 0.40 0.26 0.27 0.20 0.24
Increase / (Decrease) in Invested Capital		 -241 -262 -312 -73 209 247 336 202 154 500 440
Enterprise Value (EV)		 436 186 193 186 512 726 896 659 917 833 1,043
Market Capitalization		 433 186 188 115 430 612 776 553 755 585 725
Book Value per Share		 ($0.64) $1.49 ($1.06) $13.95 $2.63 $2.59 $2.59 $4.02 $3.46 $5.68 $4.45
Tangible Book Value per Share		 ($0.64) $1.49 ($1.06) ($1.14) ($0.09) ($0.09) ($0.05) $1.42 $1.25 $1.42 $1.21
Total Capital		 76 56 15 252 285 304 351 454 439 804 792
Total Debt		 4.92 28 5.58 92 119 140 186 197 181 381 356
Total Long-Term Debt		 0.00 28 0.00 91 119 127 170 151 167 342 238
Net Debt		 -95 -1.76 -24 70 82 114 120 106 161 249 312
Capital Expenditures (CapEx)		 0.00 0.00 0.00 0.00 0.10 0.09 0.16 0.19 0.24 0.19 0.22
Net Nonoperating Expense (NNE)		 -0.04 0.46 0.61 0.39 6.12 5.24 2.85 1.18 10 7.28 9.28
Net Nonoperating Obligations (NNO)		 4.92 28 5.58 92 119 140 186 197 181 381 356
Total Depreciation and Amortization (D&A)		 0.00 0.00 0.00 0.00 1.83 1.62 1.77 2.11 1.93 3.03 5.25
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.13 $0.01 ($0.13) ($0.02) $0.01 ($0.07) ($0.26) $0.05
Adjusted Weighted Average Basic Shares Outstanding		 24.81M 50.37M 14.13M 50.51M 63.35M 56.95M 63.03M 63.85M 74.69M 70.76M 96.19M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.13 $0.01 ($0.14) ($0.02) $0.01 ($0.07) ($0.26) $0.05
Adjusted Weighted Average Diluted Shares Outstanding		 24.81M 50.37M 14.13M 50.51M 63.35M 57.77M 63.03M 67.16M 74.69M 70.76M 97.50M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 18.34M 0.00 11.48M 62.96M 63.35M 63.69M 63.93M 74.65M 74.68M 96.85M 96.85M
Normalized Net Operating Profit after Tax (NOPAT)		 11 5.61 5.18 6.54 7.39 -1.74 0.76 4.99 4.50 -11 14
Normalized NOPAT Margin		 88.76% 21.71% 49.00% 55.78% 31.70% -8.39% 3.51% 17.05% 15.35% -33.89% 32.83%
Pre Tax Income Margin		 90.06% 31.01% 65.89% 67.40% 27.02% -51.37% -0.47% 8.23% -18.87% -51.27% 17.52%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 218.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 187.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 218.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 187.34 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 21.82% 0.00% 87.40% 119.89% 263.34% 0.00% -23.89% -9.49% -4.68% 0.00%
Augmented Payout Ratio		 0.00% 21.82% 0.00% 87.40% 119.89% 277.54% 6,561.95% -226.41% -107.47% -47.78% -17.64%

Key Financial Trends

Abacus Life (NASDAQ: ABL) has shown significant developments over the last four years based on its financial statements through Q1 2025.

Revenue and Profitability Trends:

  • Total revenue increased from approximately $11.7 million in Q2 2023 to $44.1 million in Q1 2025, indicating strong top-line growth driven mainly by non-interest income.
  • Net income recovered from losses in 2023, with a significant turnaround to a net income of $5.4 million in Q1 2025, compared to losses over prior quarters.
  • The company records zero interest income and interest expenses recently, reflecting a possible strategic shift away from traditional interest-bearing activities.
  • Net income in full-year 2023 was negative in most quarters, with the worst being Q4 2023 showing a net loss of approximately $6.2 million to common shareholders, reflecting prior periods of operational challenges.
  • Gross margins and expense ratios are affected by high non-interest operating expenses, which totaled around $23.1 million in Q1 2025, requiring monitoring for efficiency improvements.

Cash Flow and Liquidity:

  • Operating cash flow was negative in early 2024 and Q1 2025, for example, Q1 2025 saw a net cash outflow from operating activities of about $61.6 million, which could pressure liquidity if sustained.
  • Investing activities consistently resulted in outflows mainly due to the purchase of investment securities and property, leasehold improvements, and equipment, indicating ongoing investment in growth and infrastructure.
  • Financing activities in Q1 2025 resulted in net cash outflow of about $22.9 million due to debt repayments exceeding issuance, suggesting potential tightening of capital structure or deleveraging.
  • Cash and cash equivalents increased from $20.6 million in Q2 2023 to $43.8 million by Q1 2025, providing a better liquidity buffer despite negative operational cash flow.

Balance Sheet and Capital Structure:

  • Total assets roughly doubled from about $277 million in Q2 2023 to $856 million in Q1 2025, suggesting successful asset growth and expansion.
  • Long-term debt increased overall, reaching approximately $238 million in Q1 2025, up from about $91 million in mid-2023, which raises concerns around leverage and interest obligations.
  • Retained earnings remained negative but improved from approximately -$34.5 million in Q2 2024 to -$53.3 million in Q1 2025, reflecting accumulated losses but with some progress.
  • Goodwill and intangible assets grew significantly, showing acquisitions or investments in intellectual property, contributing heavily to total assets but potentially resulting in impairment risks.

Summary:

Abacus Life has exhibited strong revenue growth with a shift in its income composition towards non-interest income. Despite recent profitability improvement in Q1 2025, the company is still recovering from losses in 2023. Negative operating cash flow presents liquidity risks though balanced by a larger cash position and structural financing activities. Asset growth is considerable, but leverage increase calls for caution about debt management and financial stability.

08/18/25 01:55 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Abacus Life's Financials

When does Abacus Life's financial year end?

According to the most recent income statement we have on file, Abacus Life's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Abacus Life's net income changed over the last 2 years?

Abacus Life's net income appears to be on a downward trend, with a most recent value of -$24.92 million in 2024, falling from $32.39 million in 2022. The previous period was $9.03 million in 2023. Check out Abacus Life's forecast to explore projected trends and price targets.

How has Abacus Life's revenue changed over the last 2 years?

Over the last 2 years, Abacus Life's total revenue changed from $46.14 million in 2022 to $111.92 million in 2024, a change of 142.6%.

How much debt does Abacus Life have?

Abacus Life's total liabilities were at $450.87 million at the end of 2024, a 168.8% increase from 2023, and a 1,357.0% increase since 2022.

How much cash does Abacus Life have?

In the past 2 years, Abacus Life's cash and equivalents has ranged from $25.59 million in 2023 to $131.94 million in 2024, and is currently $131.94 million as of their latest financial filing in 2024.

How has Abacus Life's book value per share changed over the last 2 years?

Over the last 2 years, Abacus Life's book value per share changed from 1.49 in 2022 to 5.68 in 2024, a change of 282.3%.


Related Companies

This page (NASDAQ:ABL) was last updated on 8/18/2025 by MarketBeat.com Staff
From Our Partners
"AI Upgrade" Coming Sept. 1st
A new “AI Upgrade” is rolling out on September 1st—and tech leaders are calling it transformational. Softbank’...
Behind the Markets | Sponsored
New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...
Brownstone Research | Sponsored
When the levee breaks
The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...
Porter & Company | Sponsored
Think you missed gold’s boom? Think again
If you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...
Investors Alley | Sponsored
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Crypto Income (almost instantly)
How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...
Awesomely, LLC | Sponsored
National 'Stock Market Reset' Coming September 30 (New WH Order)
Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...
Altimetry | Sponsored